These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 9258278

  • 1. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat.
    Oakes ND, Camilleri S, Furler SM, Chisholm DJ, Kraegen EW.
    Metabolism; 1997 Aug; 46(8):935-42. PubMed ID: 9258278
    [Abstract] [Full Text] [Related]

  • 2. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
    Norris AW, Chen L, Fisher SJ, Szanto I, Ristow M, Jozsi AC, Hirshman MF, Rosen ED, Goodyear LJ, Gonzalez FJ, Spiegelman BM, Kahn CR.
    J Clin Invest; 2003 Aug; 112(4):608-18. PubMed ID: 12925701
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution.
    Pickavance LC, Tadayyon M, Widdowson PS, Buckingham RE, Wilding JP.
    Br J Pharmacol; 1999 Dec; 128(7):1570-6. PubMed ID: 10602338
    [Abstract] [Full Text] [Related]

  • 4. Lupin protein isolate improves insulin sensitivity and steatohepatitis in vivo and modulates the expression of the Fasn, Gys2, and Gsk3b genes.
    Soto-Luna IC, García-López PM, Vargas-Guerrero B, Guzmán TJ, Domínguez-Rosales JA, Gurrola-Díaz CM.
    Food Sci Nutr; 2021 May; 9(5):2549-2560. PubMed ID: 34026071
    [Abstract] [Full Text] [Related]

  • 5. Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice.
    Beghini M, Wagner T, Luca AC, Metz M, Kaltenecker D, Spirk K, Hackl MT, Haybaeck J, Moriggl R, Kautzky-Willer A, Scherer T, Fürnsinn C.
    PLoS One; 2021 May; 16(11):e0260501. PubMed ID: 34818373
    [Abstract] [Full Text] [Related]

  • 6. The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies.
    Amatruda M, Gembillo G, Giuffrida AE, Santoro D, Conti G.
    Medicina (Kaunas); 2021 Aug 25; 57(9):. PubMed ID: 34577791
    [Abstract] [Full Text] [Related]

  • 7. A phase II clinical trial to investigate the effect of pioglitazone on (18)F-FDG uptake in malignant lesions.
    Han YH, Kwon SY, Kim J, Na CJ, Choi S, Min JJ, Bom HS, Kim YC, Oh IJ, Chae HJ, Lim ST, Sohn MH, Jeong HJ.
    EJNMMI Res; 2015 Dec 25; 5(1):50. PubMed ID: 26408008
    [Abstract] [Full Text] [Related]

  • 8. Effects of Teucrium polium Ethyl acetate Extract on Serum, Liver and Muscle Triglyceride Content of Sucrose-Induced Insulin Resistance in Rat.
    Mousavi SE, Shahriari A, Ahangarpour A, Vatanpour H, Jolodar A.
    Iran J Pharm Res; 2012 Dec 25; 11(1):347-55. PubMed ID: 24250458
    [Abstract] [Full Text] [Related]

  • 9. Reduced plasma nonesterified fatty acid levels and the advent of an acute lung injury in mice after intravenous or enteral oleic acid administration.
    Gonçalves de Albuquerque CF, Burth P, Younes Ibrahim M, Garcia DG, Bozza PT, Castro Faria Neto HC, Castro Faria MV.
    Mediators Inflamm; 2012 Dec 25; 2012():601032. PubMed ID: 22529526
    [Abstract] [Full Text] [Related]

  • 10. Crocetin improves the insulin resistance induced by high-fat diet in rats.
    Sheng L, Qian Z, Shi Y, Yang L, Xi L, Zhao B, Xu X, Ji H.
    Br J Pharmacol; 2008 Jul 25; 154(5):1016-24. PubMed ID: 18469847
    [Abstract] [Full Text] [Related]

  • 11. Intramyocellular lipid and glycogen content are reduced following resistance exercise in untrained healthy males.
    Koopman R, Manders RJ, Jonkers RA, Hul GB, Kuipers H, van Loon LJ.
    Eur J Appl Physiol; 2006 Mar 25; 96(5):525-34. PubMed ID: 16369816
    [Abstract] [Full Text] [Related]

  • 12. Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state.
    van Loon LJ, Goodpaster BH.
    Pflugers Arch; 2006 Feb 25; 451(5):606-16. PubMed ID: 16155759
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients.
    van Loon LJ, Manders RJ, Koopman R, Kaastra B, Stegen JH, Gijsen AP, Saris WH, Keizer HA.
    Diabetologia; 2005 Oct 25; 48(10):2097-107. PubMed ID: 16096823
    [Abstract] [Full Text] [Related]

  • 14. [Future targets in the treatment of type 2 diabetes].
    Stingl H, Roden M.
    Wien Klin Wochenschr; 2004 Apr 30; 116(7-8):217-29. PubMed ID: 15143860
    [Abstract] [Full Text] [Related]

  • 15. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.
    Diamant M, Heine RJ.
    Drugs; 2003 Apr 30; 63(13):1373-405. PubMed ID: 12825962
    [Abstract] [Full Text] [Related]

  • 16. Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.
    Pickavance LC, Widdowson PS, Foster JR, Williams G, Wilding JP.
    Int J Exp Pathol; 2003 Apr 30; 84(2):83-9. PubMed ID: 12801282
    [Abstract] [Full Text] [Related]

  • 17. Diabetes: mellitus or lipidus?
    Shafrir E, Raz I.
    Diabetologia; 2003 Mar 30; 46(3):433-40. PubMed ID: 12687345
    [No Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.
    Kraegen E, Cooney G, Ye JM, Furler S.
    J R Soc Med; 2002 Mar 30; 95 Suppl 42(Suppl 42):14-22. PubMed ID: 12216322
    [No Abstract] [Full Text] [Related]

  • 19. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Wagstaff AJ, Goa KL.
    Drugs; 2002 Mar 30; 62(12):1805-37. PubMed ID: 12149047
    [Abstract] [Full Text] [Related]

  • 20. Cellular mechanisms of insulin resistance.
    Shulman GI.
    J Clin Invest; 2000 Jul 30; 106(2):171-6. PubMed ID: 10903330
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.